Moderna
MRNA
#1226
Rank
C$25.55 B
Marketcap
C$64.43
Share price
4.25%
Change (1 day)
67.43%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Earnings for Moderna (MRNA)

Earnings in 2025 (TTM): -C$3.85 Billion

According to Moderna 's latest financial reports the company's current earnings are C$1.92 Billion. , an increase over its 2024 earnings that were of -C$4.89 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Moderna from 2018 to 2025

Annual earnings

Year Earnings Change
2025 -C$3.76 Billion-23.03%
2024 -C$4.89 Billion-8.22%
2023 -C$5.32 Billion-140.65%
2022 C$13.08 B-27.81%
2021 C$18.12 B-1911.15%
2020 -C$1.01 Billion44.7%
2019 -C$0.7 Billion28.63%
2018 -C$0.54 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
C$45.70 B-1,316.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
C$22.27 B-692.89%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
C$30.54 B-913.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
-C$64.61 Million-98.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-C$0.17 Billion-95.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-C$56.89 Million-98.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
C$0.78 B-120.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
C$0.47 B-112.51%๐Ÿ‡บ๐Ÿ‡ธ USA